ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!CBIO Company Profile and Key Details
Catalyst Biosciences, Inc.
CBIO Stock Price Chart
Stock Price Today
Catalyst Biosciences, Inc. (CBIO) stock declined over -2.65%, trading at $0.51 on NASDAQ, down from the previous close of $0.53. The stock opened at $0.57, fluctuating between $0.48 and $0.58 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
South San Francisco, CA 94080
United States
Website: https://www.catalystbiosciences.comContact: 650 871 0761About Company
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD); and CB 4332 for patients with deficiencies in complement factor I (CFI), including dAMD. The company also develops ProTUNE C3b/C4b degrader and ImmunoTUNE C3a/C5a degrader platforms designed to target other disorders of the complement or inflammatory pathways. It has a strategic research collaboration with Mosaic Biosciences, Inc.; and license and collaboration agreement with Biogen International GmbH. Catalyst Biosciences, Inc. was founded in 2002 and is headquartered in South San Francisco, California.
Company Information
| Employees | 7 |
| Beta | 1.29 |
| Sales or Revenue | $794.00K |
| 5Y Sales Change% | -1% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Catalyst Biosciences, Inc. (NASDAQ: CBIO) stock price is $0.51 in the last trading session. During the trading session, CBIO stock reached the peak price of $0.58 while $0.48 was the lowest point it dropped to. The percentage change in CBIO stock occurred in the recent session was -2.65% while the dollar amount for the price change in CBIO stock was -$0.01.
The NASDAQ listed CBIO is part of Biotechnology industry that operates in the broader Healthcare sector. Catalyst Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Grant Blouse M.Sc., Ph.D.
Chief Scientific Officer
Dr. Tom Knudsen D.V.M., Ph.D.
Senior Vice President of Corporation Devel.
Dr. Nassim Usman Ph.D.
Pres, Chief Executive Officer & Director
Ms. Seline E. Miller CPA
Senior Vice President of Fin., Interim Chief Financial & Principal Accounting Officer
Ms. Ana Kapor
Senior Director of Investor Relations & Corporation Communications
CBIO's closing price is 170.96% higher than its 52-week low of $0.19 where as its distance from 52-week high of $8.69 is -94.12%.
Number of CBIO employees currently stands at 7.
Official Website of CBIO is: https://www.catalystbiosciences.com
CBIO could be contacted at phone 650 871 0761 and can also be accessed through its website. CBIO operates from 611 Gateway Boulevard, South San Francisco, CA 94080, United States.
CBIO stock volume for the day was 460.71K shares. The average number of CBIO shares traded daily for last 3 months was 437.27K.
The market value of CBIO currently stands at $19.42M with its latest stock price at $0.51 and 37.98M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com